Mechanistic Analysis of Drug Linker Clearance During Ultrafiltration/Diafiltration of an Antibody–Drug Conjugate
Biotechnology and Bioengineering · 21.08.2026
DOI: 10.1002/bit.70357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 21.08.2026. Verfasst von Vasudev Tangry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Ultrafiltration/diafiltration (UF/DF) is a key unit operation in the manufacture of antibody‐drug conjugates (ADCs), commonly utilized for post‐conjugation purification to remove residual Drug Linker (DL) compounds and affect buffer exchange. The clearance of residual drug linker (DL), however, is often well below that predicted by ideal diafiltration theory. This work provides the first detailed mechanistic analysis of the factors that influence DL clearance during constant volume diafiltration, with particular emphasis on antibody concentration, membrane properties, and operating conditions. Diafiltration experiments in both stirred cell and tangential flow filtration systems demonstrate that DL sieving coefficients decrease with increasing ADC concentration and with increasing filtrate flux. These trends are quantitatively described using a newly developed diafiltration model accounting for intermolecular association between the hydrophobic DL and the ADC, with the ADC concentration at the membrane surface evaluated using the classical concentration polarization analysis. Experimental data obtained over a range of conditions are well‐described using this concentration polarization‐binding model. The model not only explains DL clearance data, but it also provides a framework for effective process design of UF/DF processes to ensure the required levels of DL clearance during ADC purification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
- AbbVie Inc., North Chicago, Illinois, USA.
ORCID-Profile: Andrew L Zydney
Förderung
- National Science Foundation
Zitieren
APA
Tangry, V., Lyu, F., Le, A., Mlinar, L., Kelkar, M. S., & Zydney, A. L. (2026). Mechanistic Analysis of Drug Linker Clearance During Ultrafiltration/Diafiltration of an Antibody–Drug Conjugate. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70357
Vancouver
Tangry V, Lyu F, Le A, Mlinar L, Kelkar MS, Zydney AL. Mechanistic Analysis of Drug Linker Clearance During Ultrafiltration/Diafiltration of an Antibody–Drug Conjugate. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70357
BibTeX
@article{Tangry2026,
author = {Tangry, Vasudev and Lyu, Fara and Le, Amy and Mlinar, Laurie and Kelkar, Manish S and Zydney, Andrew L},
title = {Mechanistic Analysis of Drug Linker Clearance During Ultrafiltration/Diafiltration of an Antibody–Drug Conjugate},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70357}
}
EUVIMED